Penobscot Investment Management Company, Inc. Astrazeneca PLC Transaction History
Penobscot Investment Management Company, Inc.
- $1.15 Billion
- Q2 2025
A detailed history of Penobscot Investment Management Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 67,022 shares of AZN stock, worth $5.05 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
67,022
Previous 56,755
18.09%
Holding current value
$5.05 Million
Previous $4.17 Million
12.28%
% of portfolio
0.41%
Previous 0.4%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,417Shares Held
510MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.36 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...